Development of metabolic syndrome at a young age as a manifestation of familial partial lipodystrophy type 3 (PPARG mutation): the first description of its clinical case in Russia

Metabolic syndrome (MS) is extremely common (20%–25% of the world’s population), and its diagnostic criteria are defined and well known. It has been shown that patients who have MS are twice as likely to die from a cardiovascular complication and three times as likely to suffer from it compared with...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ekaterina Leonidovna Sorkina, Marina Fedorovna Kalashnikova, Natalya Vyacheslavovna Likhodey, Ekaterina Olegova Koksharova, Dmitry Vladimirovich Ustyuzhanin, Alexander Yuryevich Mayorov, Marina Vladimirovna Shestakova, Anatoly Nikolaevich Tiulpakov
Format: article
Langue:EN
RU
Publié: Endocrinology Research Centre 2015
Sujets:
Accès en ligne:https://doaj.org/article/4fbbd980baef4951b83935980887ef05
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!